343 related articles for article (PubMed ID: 18058469)
1. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
2. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
[TBL] [Abstract][Full Text] [Related]
3. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans.
Jang Y; Kim JY; Kang SM; Kim JS; Chae JS; Kim OY; Koh SJ; Lee HC; Ahn CW; Song YD; Lee JH
Metabolism; 2007 Feb; 56(2):199-205. PubMed ID: 17224333
[TBL] [Abstract][Full Text] [Related]
4. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
[TBL] [Abstract][Full Text] [Related]
5. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
6. Glyoxalase I Glu111Ala polymorphism in patients with breast cancer.
Germanová A; Germanová A; Tesarová P; Jáchymová M; Zvára K; Zima T; Kalousová M
Cancer Invest; 2009 Jul; 27(6):655-60. PubMed ID: 19452310
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
8. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
[TBL] [Abstract][Full Text] [Related]
9. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
[TBL] [Abstract][Full Text] [Related]
10. Soluble receptor for advanced glycation end products in patients with decreased renal function.
Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T
Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618
[TBL] [Abstract][Full Text] [Related]
11. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
[TBL] [Abstract][Full Text] [Related]
12. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
Catalano M; Cortelazzo A; Santi R; Contino L; Demicheli M; Yilmaz Y; Zorzetto M; Campo I; Lanati N; Emanuele E
Clin Biochem; 2008 Aug; 41(12):981-5. PubMed ID: 18538667
[TBL] [Abstract][Full Text] [Related]
13. Association of biochemical parameters and RAGE gene polymorphisms in healthy infants and their mothers.
Boor P; Celec P; Klenovicsová K; Vlková B; Szemes T; Minárik G; Turna J; Sebeková K
Clin Chim Acta; 2010 Aug; 411(15-16):1034-40. PubMed ID: 20359471
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum levels of advanced glycation end products and their monocyte receptors in patients with type 2 diabetes.
Su XD; Li SS; Tian YQ; Zhang ZY; Zhang GZ; Wang LX
Arch Med Res; 2011 Oct; 42(7):596-601. PubMed ID: 22100610
[TBL] [Abstract][Full Text] [Related]
15. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
16. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
Norata GD; Garlaschelli K; Grigore L; Tibolla G; Raselli S; Redaelli L; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
[TBL] [Abstract][Full Text] [Related]
17. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
[TBL] [Abstract][Full Text] [Related]
18. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
Germanová A; Koucký M; Hájek Z; Parízek A; Zima T; Kalousová M
Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
[TBL] [Abstract][Full Text] [Related]
19. Low levels of plasma soluble receptor for advanced glycation end products are associated with severe leukoaraiosis in acute stroke patients.
Yokota C; Minematsu K; Tomii Y; Naganuma M; Ito A; Nagasawa H; Yamaguchi T
J Neurol Sci; 2009 Dec; 287(1-2):41-4. PubMed ID: 19801152
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia.
Emanuele E; D'Angelo A; Tomaino C; Binetti G; Ghidoni R; Politi P; Bernardi L; Maletta R; Bruni AC; Geroldi D
Arch Neurol; 2005 Nov; 62(11):1734-6. PubMed ID: 16286548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
